Multiple Sclerosis (MS) patients present a decrease of antioxidants and neuroprotective and immunoregulatory vitamins and an increase of total homocysteine (tHcy), cholesterol (CHL), HDLcholesterol, and of cellular stress markers, variably associated with the different phases of the disease. We compared the blood levels of uric acid, folic acid, vitamins B12, A, and E, tHcy, CHL, HDL-cholesterol, and triglycerides in forty MS patients during a phase of clinical inactivity with those of eighty healthy controls, matched for age and sex. We found higher levels of tHcy (p = 0.032) and of HDL-cholesterol (p = 0.001) and lower levels of vitamin E (p = 0.001) and the ratio vitamin E/CHL (p = 0.001) in MS patients. In conclusion, modifications of some biochemical markers of cell damage were detected in MS patients during a phase of clinical inactivity.

Salemi, G., Gueli, M.C., Vitale, F., Battaglieri, F., Guglielmini, E., Ragonese, P., et al. (2010). Blood Lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients. LIPIDS IN HEALTH AND DISEASE, 9, 19-21 [10.1186/1476-511X-9-19].

Blood Lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients

SALEMI, Giuseppe;GUELI, Maria Concetta;VITALE, Francesco;GUGLIELMINI, Egidio;RAGONESE, Paolo;MASSENTI, Maria Fatima;BONO, Antonino
2010-01-01

Abstract

Multiple Sclerosis (MS) patients present a decrease of antioxidants and neuroprotective and immunoregulatory vitamins and an increase of total homocysteine (tHcy), cholesterol (CHL), HDLcholesterol, and of cellular stress markers, variably associated with the different phases of the disease. We compared the blood levels of uric acid, folic acid, vitamins B12, A, and E, tHcy, CHL, HDL-cholesterol, and triglycerides in forty MS patients during a phase of clinical inactivity with those of eighty healthy controls, matched for age and sex. We found higher levels of tHcy (p = 0.032) and of HDL-cholesterol (p = 0.001) and lower levels of vitamin E (p = 0.001) and the ratio vitamin E/CHL (p = 0.001) in MS patients. In conclusion, modifications of some biochemical markers of cell damage were detected in MS patients during a phase of clinical inactivity.
2010
Settore MED/26 - Neurologia
Settore BIO/10 - Biochimica
Salemi, G., Gueli, M.C., Vitale, F., Battaglieri, F., Guglielmini, E., Ragonese, P., et al. (2010). Blood Lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients. LIPIDS IN HEALTH AND DISEASE, 9, 19-21 [10.1186/1476-511X-9-19].
File in questo prodotto:
File Dimensione Formato  
Salemi et al. (2010) Lipids in Health and Disease.pdf

Solo gestori archvio

Dimensione 183.27 kB
Formato Adobe PDF
183.27 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/46395
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 49
social impact